PharmaBoardroom

Serbia macroeconomic factsheet including data on population, GDP, education and life expectancy. Serbia has risen 50 places in the World…

The top 10 pharmaceutical companies in Canada for 2016 in terms of total sales and market share. Johnson & Johnson leads the way with USD 2.93…

In a market environment that, up until recently, has been severely difficult for producers of chemical pharmaceutical products to operate in, three…

Maciej Wieczorek, president of Celon Pharma, discusses the award-winning success of the 2016 IPO on the Warsaw stock exchange and the opportunities…

Nadurel Pharma, headquartered in the technopole of Saint-Hyacinthe, Quebec, promotes natural health products complete with concrete clinical trial…

For multinational companies, despite ‘pharmerging markets’ not holding the hype and allure they once did, India still stands as a land of…

Umang Vohra, managing director and global CEO of Indian pharma giant Cipla, discusses the company’s ambition to grow in both the domestic and…

Jaiveer Singh, CEO of Mint Pharmaceuticals explains the company’s business model and how it fits the characteristics of the Canadian market on the…

Between 2010 and 2012 just one of the 139 new medicines to receive market authorisations globally was approved for reimbursement in Serbia, compared…

Iwona Skrzekowska-Baran, owner and CEO of Pharm&Med, a young, exciting Polish consultancy that is helping clients to transform evidence, policy…

Nebojsa Skuljec has held various positions in MSD Healthcare across the Balkans before his promotion to country lead for Serbia and Balkans emerging…

Branislav Kotlarik, Ferring’s general manager for the Balkans - whose remit includes Hungary, Romania and Bulgaria as well as all of ex-Yugoslavia…